SteadyMD, AmerisourceBergen partner for pharmacy telehealth and more digital health briefs
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili’s EndeavorRx shows promise for adults with ADHD.
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili’s EndeavorRx shows promise for adults with ADHD.
Go to Source
2023-05-05 20:53
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
